A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19
暂无分享，去创建一个
R. Pandey | A. Lahiri | S. Chatterjee | R. Maurya | A. Kanakan | A. Roy | D. Raychaudhuri | J. Sarif | D. Ganguly | Moumita Saha | P. Bhattacharya | Y. Ray | B. Saha | P. Bandopadhyay | R. D’Rozario | S. R. Paul | R. Roy | S. Bagchi | A. Maiti | B. Sarkar | J. Vasudevan | Sachin Sharma | D. Biswas | C. Maiti | S. Sengupta | Manish Kumar | S. Chakraborty | Praveen Singh | Debaleena Bhowmik | Sandip Paul | A. Haldar | A. Mondal | Ritwik Bhaduri | Kausik Chaudhury | Rajsekhar Maiti | Md. Masoom Perwez | Avinash Tewari | Samik Mandal | S. Mandal | Abhinandan Mondal | A. Tewari